Financial Comparison: Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) & Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) and Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, earnings, dividends, analyst recommendations, risk, valuation and institutional ownership.

Insider and Institutional Ownership

93.8% of Embecta shares are held by institutional investors. Comparatively, 12.4% of Senseonics Holdings, Inc. Common Stock shares are held by institutional investors. 1.3% of Embecta shares are held by insiders. Comparatively, 4.7% of Senseonics Holdings, Inc. Common Stock shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Embecta and Senseonics Holdings, Inc. Common Stock, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Embecta	2	3	0	0	1.60
Senseonics Holdings, Inc. Common Stock	1	1	4	0	2.50

Embecta currently has a consensus price target of $11.00, suggesting a potential upside of 108.53%. Senseonics Holdings, Inc. Common Stock has a consensus price target of $17.20, suggesting a potential upside of 79.54%. Given Embecta’s higher probable upside, equities research analysts plainly believe Embecta is more favorable than Senseonics Holdings, Inc. Common Stock.

Valuation & Earnings

This table compares Embecta and Senseonics Holdings, Inc. Common Stock”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Embecta	$1.08 billion	0.28	$95.40 million	$1.48	3.56
Senseonics Holdings, Inc. Common Stock	$35.26 million	11.36	-$69.11 million	($2.23)	-4.30

Embecta has higher revenue and earnings than Senseonics Holdings, Inc. Common Stock. Senseonics Holdings, Inc. Common Stock is trading at a lower price-to-earnings ratio than Embecta, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Embecta and Senseonics Holdings, Inc. Common Stock’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Embecta	8.59%	-19.25%	10.82%
Senseonics Holdings, Inc. Common Stock	-225.09%	-165.80%	-80.14%

Risk & Volatility

Embecta has a beta of 0.86, suggesting that its share price is 14% less volatile than the S&P 500. Comparatively, Senseonics Holdings, Inc. Common Stock has a beta of 1.08, suggesting that its share price is 8% more volatile than the S&P 500.

Summary

Embecta beats Senseonics Holdings, Inc. Common Stock on 9 of the 14 factors compared between the two stocks.

About Embecta

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.

About Senseonics Holdings, Inc. Common Stock

Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company’s products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company has a collaboration agreement with the University Hospitals Accountable Care Organization. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.